ESPR
Esperion Therapeutics, Inc.
$3.19
+0.03 (+0.95%)
At close · Jul 8
Market Cap
$821.21M
Shares
257,431,942
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-08 | — | |
| 8-K/A | 2026-06-18 | 2026-04-02 | |
| 8-K | 2026-06-16 | 2026-06-15 | |
| 8-K | 2026-06-09 | 2026-06-02 | |
| 8-K | 2026-06-01 | 2026-05-28 | |
| 10-Q | 2026-05-08 | 2026-03-31 | |
| 8-K | 2026-05-01 | — | |
| DEF 14A | 2026-04-16 | — | |
| 8-K | 2026-04-02 | — | |
| 8-K | 2026-03-10 | — | |
| 10-K | 2026-03-10 | 2025-12-31 | |
| 8-K | 2026-03-03 | 2026-03-02 | |
| 8-K | 2026-01-12 | 2026-01-11 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-11-04 | — | |
| 8-K | 2025-10-08 | 2025-10-07 | |
| 8-K | 2025-10-07 | — | |
| 10-Q | 2025-08-13 | 2025-06-30 | |
| 8-K/A | 2025-08-11 | 2025-08-05 | |
| 8-K | 2025-08-05 | — | |
| 8-K | 2025-07-01 | — | |
| 8-K | 2025-06-02 | 2025-05-29 | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-06 | — | |
| DEF 14A | 2025-04-17 | — | |
| 8-K | 2025-04-04 | — | |
| 8-K | 2025-04-01 | — | |
| 10-K | 2025-03-07 | 2024-12-31 | |
| 8-K | 2025-03-04 | — | |
| 8-K | 2025-01-16 | 2025-01-15 | |
| 8-K | 2024-12-18 | 2024-12-17 | |
| 8-K | 2024-12-13 | 2024-12-12 | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-08-12 | — | |
| 10-Q | 2024-08-12 | 2024-06-30 | |
| 8-K | 2024-08-05 | 2024-08-03 | |
| 8-K | 2024-06-28 | 2024-06-27 | |
| 8-K | 2024-05-28 | 2024-05-23 | |
| 8-K | 2024-05-08 | — | |
| 10-Q | 2024-05-07 | 2024-03-31 | |
| 8-K | 2024-05-07 | — | |
| DEF 14A | 2024-04-11 | — | |
| 8-K | 2024-02-27 | — | |
| 10-K | 2024-02-27 | 2023-12-31 | |
| 8-K | 2024-01-22 | 2024-01-18 | |
| 8-K | 2024-01-18 | — | |
| 8-K | 2024-01-11 | 2024-01-10 | |
| 8-K | 2024-01-03 | 2024-01-02 |
Showing 1–50 of 128 filings